SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 31 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $34,000 | -37.0% | 60,432 | -29.2% | 0.00% | 0.0% |
| Q1 2017 | $54,000 | -59.4% | 85,348 | -51.2% | 0.00% | -66.7% |
| Q4 2016 | $133,000 | +166.0% | 174,898 | +503.7% | 0.00% | +200.0% |
| Q3 2016 | $50,000 | -52.8% | 28,969 | -51.0% | 0.00% | -50.0% |
| Q2 2016 | $106,000 | -70.7% | 59,109 | -62.6% | 0.00% | -66.7% |
| Q4 2015 | $362,000 | +238.3% | 158,231 | +235.2% | 0.01% | +200.0% |
| Q3 2015 | $107,000 | +214.7% | 47,203 | +292.7% | 0.00% | +100.0% |
| Q2 2015 | $34,000 | -80.7% | 12,019 | -85.0% | 0.00% | -75.0% |
| Q1 2015 | $176,000 | +47.9% | 80,352 | -1.4% | 0.00% | +100.0% |
| Q4 2014 | $119,000 | +60.8% | 81,497 | +97.3% | 0.00% | +100.0% |
| Q3 2014 | $74,000 | – | 41,306 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,034,949 | $1,553,000 | 2.72% |
| Third Security, LLC | 13,238,268 | $10,095,000 | 0.54% |
| MSD Partners, L.P. | 4,118,402 | $3,141,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 3,031,953 | $2,312,000 | 0.13% |
| Alyeska Investment Group, L.P. | 10,000,000 | $7,626,000 | 0.06% |
| BARD ASSOCIATES INC | 87,999 | $67,000 | 0.03% |
| Alyeska Investment Group, L.P. | 4,586,592 | $3,498,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 126,000 | $96,000 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,000,000 | $763,000,000 | 0.02% |
| HAMILTON LANE ADVISORS LLC | 23,855 | $18,000 | 0.01% |